President Donald Trump is trying to fast-track research into psychedelics as treatments, creating new opportunities and risks.
Recent Posts
- Dow jumps 900 points, Nasdaq slides as investors rotate out of chip stocks for banks, retail: Live updates
- Long-term unemployment is surging in the U.S. There are hidden costs for workers and the economy
- Blackstone restricts flagship fund withdrawals as private asset fears reemerge
- Kalshi is building a prediction markets ‘Bloomberg Terminal’ for high-end traders, source says
- Micron, Marvell, and Broadcom lead chipmakers’ premarket losses